Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Conditions
Epilepsy · Seizures, Epileptic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Green Leaf Clinical Trials, LLC, Jacksonville, Florida, United States
Visionary Investigators Network, Miami, Florida, United States
Prince of Wales Hospital, Randwick, New South Wales, Australia
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Westmead Hospital, Sydney, New South Wales, Australia
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Box Hill Hospital, Box Hill, Victoria, Australia
The Austin Hospital, Heidelberg, Victoria, Australia
The Alfred Hospital, Melbourne, Victoria, Australia
Contact: Principal Investigator (Terence O'Brien, MD)The Royal Melbourne Hospital, Parkville, Victoria, Australia
Study leads
Maciej Gasior, MD, PhD
Study Director
Supernus Pharmaceuticals